Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study.

Introduction: Use of androgen deprivation therapy (ADT) in carcinoma prostate (CaP) has deleterious effect on bone mineral density (BMD) leading to increase incidence of osteoporosis and skeletal-related events. We evaluated bone health status and impact of bone-directed therapy (BDT) and ADT on BMD in these patients from Jan 2015-Dec 2018.

Materials And Method: Baseline bone health was assessed using Tc-99 MDP Bone scan/DEXA scan for patients on ADT.